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Lipid transferThe in vitro activity of the ceramide transporter, CERT has been studied using a ﬂuorescence assay. CERT is
responsible for the in vivo non-vesicular trafﬁcking of ceramide between the endoplasmic reticulum and
Golgi. In this study we have examined how the membrane environment surrounding the ceramide substrate,
the membrane packing density and the membrane charge, are affecting the ceramide transfer activity. To
examine this we have used an anthrylvinyl-labeled ceramide analogue. We found that if ceramide is in a
tightly packed environment such as in sphingomyelin or dipalmitoylphosphatidylcholine containing
membranes, the CERT transfer activity is markedly reduced. Ceramide in ﬂuid membranes on the other
hand are available for CERT mediated transfer. CERT also favors membranes that contain phosphatidylinositol
4-monophospate, due to its binding capacity of the pleckstrin homology domain towards phosphatidylino-
sitol 4-monophospate. From this study we conclude that the membrane matrix surrounding ceramide, that is
ceramide miscibility, is largely affecting the transfer activity of CERT.oyl]sphingosine; CERT, ceramide
perchlorate; DOPC, 1,2-dioleoyl-
cero-3-phosphocholine; ER, en-
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Ceramide is a precursor of several important lipids such as
sphingomyelin (SM) and a large number of glycosphingolipids.
Ceramide plays a key role as a lipid messenger in cell signaling, and
it has also been proposed to be a regulator of cell apoptosis [1,2]. The
synthesis and organization of lipids are precisely regulated, and these
processes occur at the endoplasmic reticulum (ER) and the Golgi
complex. Ceramide is synthesized at the ER and is later transported to
other locations. It can either undergo vesicular trafﬁcking to the cis-
Golgi, where it is converted to glucosylceramide (GlcCer) or it can be
transported to the trans-Golgi for conversion to sphingomyelin (SM).
This latter step is mainly catalyzed by a lipid transfer protein called
the ceramide transfer protein, CERT [3].The ceramide transfer protein was found when non-vesicular
transport of ceramide between ER and Golgi was studied. The protein
was shown to be cytosolic and to consist of three domains; a lipid
transfer domain, a pleckstrin homology (PH) domain and an ER-
targeting domain [3]. The START (steroidogenic acute regulatory
protein-related lipid transfer) domain, located at the C-terminus,
binds ceramide and is catalyzing the interorganelle ceramide transfer.
The N-terminal PH domain of CERT targets the protein to Golgi through
recognition and binding to phosphatidylinositol 4-monophospate
(PI4P) and is regulated by the phosphatidylinositol 4-kinase III beta
[4]. Themiddle part of the CERT sequence contains amotif targeting the
protein to the ER [5]. Thismotif is called FFAT (two phenylalanines in an
acidic tract) and it was shown to enable CERT to interact with the
VAPs, vesicle-associated membrane protein-associated proteins
(VAMP-associated proteins) located on the cytosolic surface of the ER
[5,6]. Several other important lipid transport proteins have been
reported to bind to the VAPs through FFAT or FFAT like motifs [7,8].
The structure of the CERT START domain was recently resolved
both in its apo-form as well as bound to ceramide having different
acyl chains [9]. The cavity of CERT was shown to be amphiphilic with
an important glutamate residue at position 446 (Glu-446) that is
crucial for ceramide transfer. Moreover the domain contained two
tryptophans (Trp-473 and/or Trp-562) exposed on the surface that
were suggested to be important for membrane interaction. By using
the surface plasma resonance (SPR) technique it was recently
conﬁrmed that Trp-473 is indeed necessary for membrane binding
and, furthermore, the molecular mechanisms behind the inhibiting




Fig. 1. AV-Ceramide characterization. The ﬂuorescent probe anthrylvinyl-ceramide
molecular weight 655.99 g/mol (A), with C18 sphingosine was used tomonitor the CERT
mediated ceramide transfer (B). Normalized excitation (emission, 430 nm) and
emission (excitation, 370 nm) spectra of AV-Cer probe in ethanol (C). MS data, 654.5
[M−H]−, 678.5 [M + Na]+, 679.5 [M + H + Na]+, 694.4 [M + K]+.
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hydroxymethyl-3-phenylpropyl)alkanamide) was explained
[10,11].
Previously it has been shown that CERT is speciﬁc for ceramide
substrates having acyl chains consisting of 14, 16, 18 and 24 carbon
atoms [12]. In the same study it was also demonstrated that SM,
sphingosine, cholesterol and phosphatidylcholine are not transferred by
CERT. In this study we also conﬁrmed that CERT is not able to move
glycosphingolipids, such as galactosylceramide. So far no information
exists whether other lipids surrounding ceramide in themembrane are
affecting the ceramide transport mediated by CERT. Therefore, we
investigate this using a ﬂuorescent probe, anthrylvinyl-labeled cer-
amide as a ceramide analogue to measure the transfer of ceramide by
CERT. This was performed by using a resonance energy transfer (RET)
method that has successfully been used when analyzing another lipid
transfer protein, the glycolipid transfer protein (GLTP) [13]. We now
provide evidence that the ceramide transport is affected by several
parameters affecting the surrounding matrix of the ceramide molecule.
Furthermore, we show that the transport is sensitive to PI4P that
appears to attract CERT and enhance the transfer.
2. Materials and methods
2.1. Materials
sn-1-Palmitoyl-2-oleoyl-phosphatidylcholine (POPC), sn-1,2-dipal-
mitoyl-phosphatidylcholine (DPPC), cholesterol, phosphatidylinositol
4-monophospate (PI4P), phosphatidylinositol (PI), palmitoylsphingo-
myelin (P-SM), sn-1,2-dioleoylphosphatidylcholine (DOPC) and C8-
ceramide were all from Avanti Polar Lipids (AL, USA). 3,3′-dihexadecy-
loxacarbocyanine perchlorate (DiO-C16)was from Invitrogen (OR, USA),
N-[12-(9-anthryl)-11E-dodecenoyl]sphingosine (AV-Cer) was synthe-
sized as described in the next paragraph. Anthrylvinyl-labeled galacto-
sylceramide (AV-GalCer) was synthesized as previously described [14].
2.2. Preparation of AV-Cer
12-(9-Anthryl)-11E-dodecenoic acid (11 mg, 29 μmol) [15], (ben-
zotriazole-1-yloxy)tris-(dimethylamino)phosphonium hexaﬂuoro-
phosphate (BOP, 14 mg, 32 μmol) and 15 μl 1-methylimidazole were
dissolved in 1 ml dry chloroform by vortexing; after 1-h incubation, a
solution of D-sphingosine sulfate (from bovine brain sphingomyelin;
Sigma, MO, USA.) (10 mg, 26.7 μmol) in 2 ml chloroform and 0.5 ml
isopropanol was added, stirred for 6 h at 24 °C and left overnight.
Chromatography of reaction products on a silica gel column in
chloroform with 0→2% methanol gave 15 mg (the reaction yield was
86%) AV-Cer as yellowish amorphous powder, individual by thin-
layer chromatography on Kieselgel 60 pre-coated plates (Merck,
Germany), Rf=0.40 in chloroform-methanol, 19:1 v/v, system,
detection with phosphomolybdic acid, and with UV light. Its UV
(λmax 351, 368 and 387 nm, in ethanol) and ﬂuorescence (λem 430,
shoulder 412 nm, in ethanol) spectra are the same as of other
anthrylvinyl probes, Fig. 1 [16]. The purity and identity of AV-Cer was
positively veriﬁed by ESI-MS (HCT-Ultra ion trap mass spectrometer;
Bruker Daltonics, Germany), Fig. 1.
2.3. Protein expression and puriﬁcation of CERT and mutant CERT ΔST in
Escherichia coli
The construction of the human CERT plasmids has previously been
described [3]. His-tagged hCERT and CERTΔST were transformed in E.
coli BL-21 (DE3) cells, and grown at 37 °C until A600 reached 0.6. The
expression of the CERT proteins was induced by addition of isopropyl
1-thio-β-D-galactopyranoside and the bacteria were grown at 25 °C
for an additional 4 h. The bacteria were lysed and puriﬁed on a TALON
metal afﬁnity resin (BD Biosciences Clontech) according to themanufacturer's instructions. The protein concentration was deter-
mined by the method of Lowry [17].
2.4. Preparation of phospholipid vesicles by probe sonication
The donor vesicles had different compositions, containing the
ﬂuorophore holder AV-Cer, quencher DiO-C16 and a varying matrix
lipid. The lipid mixtures were dried under nitrogen and dissolved in a
10-mM sodium phosphate buffer (pH 7.4) containing 1 mM dithio-
threitol, 140 mMNaCl and 1 mM EDTA. The suspension was sonicated
using a Branson 250 titanium probe (micro tip with a diameter of
3 mm) soniﬁer and centrifuged for 15 min at 15000 g to remove
multilamellar aggregates and titanium probe particles. The acceptor
vesicles contained 10 times the molar concentration lipids compared
to donor vesicles. The size of the vesicles has previously been
determined to be about 45 nm in diameter using light scattering
measurements [18], Malvern Zetasizer Nano-S ZEN1600, Malvern
Instruments (Worcestershire, UK). The POPC acceptor vesicles were
also prepared by sonication as described above for the sonicated
donor vesicles.
2.5. Resonance energy transfer assay
The ﬂuorescence method used for measuring the transfer of
ceramide between two bilayer vesicle populations was adopted from
another assay that measures glycolipid transfer, previously thorough-
ly described [13,18]. Probe sonicated vesicles consisting of 1% AV-Cer,
3% DiO-C16 (nontransferable quencher), and a varying lipid. The assay
was started by injection of 10 μg of CERT. The assay as well as the
vesicle preparation was done in a 10 mM sodium phosphate buffer
Fig. 2. Upper panel, ﬂuorescence anisotropy of POPC:C8-Cer:AV-Cer, 95:4:1 (black
trace), or 80:19:1 (grey trace) between 40 and 90 °C. Excitation was detected at
370 nm, and emission was detected at 430 nm. The arrow indicates the melting
temperature of 64 °C for C8-Cer. Lower panel shows a typical CERT (10 μg) mediated
transfer of AV-Cer, compared to the inactive CERT mutant, as well as the inability of
CERT to transfer AV-GalCer. The arrow in the lower panel indicated the addition of CERT
to the transfer assay containing donor and acceptor vesicles. Donor vesicles were
composed of either AV-Cer or AV-GalCer with the DiO-C16 quencher in POPC. POPC
acceptor vesicles were in 10-fold excess compared to the donor vesicles.
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EDTA at 37 °C. The transfer rates in the ﬁrst minute after CERT
injection, initial transfer, could be calculated by comparing the
increase in the ﬂuorescence intensity (unquenching) and comparing
this value to the total ﬂuorescence intensity obtained when treating
the sample with Triton X-100 (ﬁnal concentration 1%) subtracted
with the Triton X-100 blank. For a more detailed explanation of the
calculations, see previously published data [19]. Data in Figs. 3, 4 and 5
are obtained from two different CERT expression and puriﬁcation
batches. Each vesicle composition is made in triplicate preparations
and assayed at least in triplicates. The data points are average transfer
rates calculated from both protein batches.
2.6. Fluorescence anisotropy of AV-Cer
Fluorescence anisotropy of anthrylvinyl-labeled ceramide was
registered on a PTI QuantaMaster 1 spectroﬂuorimeter (Photon
Technology International, Lawrenceville, NJ) that operates in the T-
format. Samples contained POPCwith 1-mol%AV-Cer and 4- or 19-mol%
C8-ceramide. The melting temperature Tm for C8-ceramide is 64.4 °C as
determined by differential scanning calorimetry [20]. The samples of
bath sonicated multilamellar vesicles were excited at 370 nm, and the
emissionwas recorded at 430 nm,with all the slits set to 5 nm. The scan
(from 40 to 90 °C) was done in a quartz cuvette under constant stirring,
and the temperaturewas controlled bya Peltier element. The anisotropy
was calculated with the PTI software package. Representative scans
were chosen from multiple experiments.
3. Results
3.1. AV-Cer reports the melting of C8-ceramide in POPC bilayers
CERT efﬁciently transfers ceramides with C14, C16, C18, and C20
amide-linked acyl chains, but not longer acyl chains. CERTalso facilitates
the transfer of C16-dihydro- and phytoceramide [12]. In addition,
binding assays showed that CERT recognizes short chain ﬂuorescent
analogs such as C5-BODIPY-ceramide and C6-NBD-ceramide with a
stoichiometry of 1:1 [12]. Because short chain ﬂuorescent analogs of
lipids have a high spontaneous transfer between membranes [21] they
are unsuitable in protein mediated lipid transfer assays. Therefore, we
have in this assay used an anthrylvinyl-labeled ceramidewith a C12 acyl
chain linked ﬂuorophore.
To validate the AV-Cer probe, we show the anisotropy values of
AV-Cer in C8-ceramide/POPC probe-sonicated vesicles versus tem-
perature (Fig. 2 upper panel). The Tm for the thermodynamic gel to
liquid phase transition of C8-ceramide corresponded well with the
change in the anisotropy value (arrow in Fig. 2, upper panel). The
change in the anisotropy was around 62–64 °C. We therefore
conclude that, at low concentrations, such as those used under our
experimental conditions, AV-Cer disperses with short ceramides and
reports their melting.
We also used a CERTmutant that does not have the START domain,
and clearly show that it does not have any transfer activity, compared
to the wild-type trace that shows a normal transfer activity (Fig. 2,
lower panel). This also shows that AV-Cer will remain in the donor
vesicles and does not show any signiﬁcant spontaneous transfer.
In another control experiment, we examined the ability of CERT to
facilitate the movement of another sphingolipid, anthrylvinyl-labeled
galactosylceramide, AV-GalCer. We show that CERT is not able to
transfer AV-GalCer from donor membranes to acceptor membranes
(Fig. 2, lower panel), as is anticipated based on previous studies [12].
Neither does another transfer protein, glycolipid transfer protein
(GLTP), show any transfer activity for AV-Cer (data not shown). The
mutant CERT ΔST (START domain deleted) is neither transferring AV-
Cer nor AV-GalCer (data not shown). Based on these results weconclude that AV-Cer is a suitable probe for examining the in vitro
CERT mediated transfer.3.2. Transfer of AV-Cer from donor vesicles containing different
compositions of DOPC; DPPC or SM
We have examined the CERT activity as a function of different
matrices; in particular, the ﬂuidity of the donor membranes was
examined. We started with POPC (melting temperature −4 °C)
membranes with AV-Cer and the quencher DiO-C16 with increasing
DOPC (melting temperature−18 °C) to generate an environment with
increasingﬂuidity. At the temperature of 37 °C, a 30–40% increase in the
transfer of AV-Cer can be seen with the addition of 25% DOPC to the
POPC donors vesicles (Fig. 3A). A further increase in the DOPC amount
did not further change the rate of AV-Cer. When POPC is replaced with
DOPC thematrix becomes fully unsaturated and AV-Cerwill most likely
be completely phase separated into AV-Cer rich domains, readily
available for CERT. A successive increase in the DPPC (melting
temperature 42 °C) content to POPC to generate a more rigid donor
membrane resulted in a stepwise lowering of the AV-Cer transfer rate
(Fig. 3B). CERT was not able to transfer any AV-Cer from donor



























































































Fig. 3. CERT activity is dependent on the lipids surrounding the AV-Cer substrate. (A)
Different amounts of DOPC (0, 25, 50, 75, 100 mol%) was included into POPC donor
vesicles and the AV-Cer (1 mol%) transfer to POPC acceptor vesicles was examined. The
level of transfer of AV-Cer for the 100% POPC (0% DOPC) mixture is signiﬁcantly lower
(Pb0.001) than the other mixtures. (B) Donor vesicles containing different mol% of
DPPC (0, 25, 50, 75, 100 mol%) in POPC. (C) Donor vesicles composed of different mol%
of SM (0, 25, 50, 75, 100 mol%) in POPC. Results in A and B are means ± SD of two
independent sets of CERT batches and in C of one batch. Transfer rates are averages of at
least triplicate transfer measurements per batch. The transfer is normalized to 1 for the
sample containing AV-Cer donor vesicles composed of only POPC. 10 μg of CERT was
used in the assay.
Fig. 4. CERT-mediated transfer of AV-Cer (1 mol%) from POPC (diamonds), DPPC
(squares) or POPC/DPPC [1:1] (triangles) vesicles containing increasing amounts of
cholesterol. Results for POPC and DPPC vesicles are means ± SD of two independent
CERT puriﬁcation batches and for POPC/DPPC (1:1) vesicles of one batch. Data are
averages of at least triplicate samples per protein batch. 10 μg of CERT was used in the
assay. The levels of transfer of AV-Cer for the 5% and 10% cholesterol in POPC/DPPC
(1:1) mixtures (green) are signiﬁcantly higher (Pb0.005) than the 5% and 10%
cholesterol in DPPC (red).
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mediated AV-Cer transfer, and no AV-Cer was moved from 100% P-SM
(Fig. 3C). AV-Cer is likely to bemore soluble in the gel phasemembranes
and more dispersed and not as readily available for CERT.
3.3. Transfer of AV-Cer from donor vesicles containing different
compositions of DOPC, DPPC and cholesterol
One function of cholesterol in tightly packed membranes is to
maintain the ﬂuidity, and in ﬂuid membranes to minimize acyl chain
trans-gauche conﬁguration and thus make the membrane more rigid.
Addition of cholesterol up to 20 mol% to POPC vesicles did not, to any
signiﬁcant portion, change the AV-Cer transfer rate (Fig. 4, blue
diamonds). Cholesterol was not able to cause any greater transfer of
AV-Cer from DPPCmembranes (Fig. 4, red squares). In the POPC/DPPC
1:1 mixture cholesterol at 5 and 10 mol% was able to increase slightly
the CERT mediated transfer of AV-Cer (Fig. 4, green triangles),compared to the no-cholesterol sample. Higher cholesterol amounts
on the other hand returned the transfer rate of AV-Cer to zero.
3.4. Effects of PI4P and PI on the transfer of AV-Cer
PI4P promotes the recruitment of different lipid transfer proteins
OSBP1, CERT and FAPP2 through the PH domain, causing further
changes in the lipid composition of these target membrane domains
[22]. FAPP2 transfers GlcCer to the trans-Golgi network, whereas
OSBP1 senses the levels of cholesterol in the trans-Golgi network
membranes [23]. We analyzed the effect of PI4P present in
membranes with regard to the CERT mediated transfer of AV-Cer. If
PI4P is present in the acceptor membranes between 1 and 4 mol%, the
transfer rate slows down to between 30% and 40%. With PI present,
the rate is not slowed down to the same extent (Fig. 5A). If donors
vesicles contain PI4P in 1 mol% it caused amuch faster AV-Cer transfer
rate compared to equivalent amounts of PI containing donor
membranes (Fig. 5B). These experiments were done in the presence
of 140 mM NaCl that should eliminate simple charge–charge inter-
actions between CERT and the negatively charged lipids.
4. Discussion
CERT, a splicing variant of Goodpasture antigen-binding protein
(GPBP), consists of three regions [24]. These are an N-terminal region
with a PH domain that binds to PI4P, a middle region containing a
FFAT motif that participates in the association with the ER, and in the
C-terminal region the START domain that extracts ceramide from
donor membranes and releases the bound ceramide to acceptor
membranes [25,26]. The other splice variant, GPBP, a protein with an
additional 26 amino acid serine-rich domain, is associated with
collagen IV in patients with the autoimmune disease Goodpasture
syndrome. The two splice forms carry out different functions in
speciﬁc sub-cellular localizations [26].
It has previously been shown that CERT is not able to transfer SM,
phosphatidylcholine and cholesterol [12], consequently we therefore
assumed that CERT is only transferring ceramide from membranes
and not other lipids. In this study, we used anthrylvinyl (AV) as the
ﬂuorescent label positioned on the amide linked acyl chain on the
ceramide molecule to measure the CERT-mediated transfer. AV-
labeled galactosylceramide has previously been utilized when
examined the transfer activity of GLTP [18,27,28]. The anthrylvinyl
moiety of AV-Cer reportedly localizes to the hydrophobic region of the
Fig. 5. CERT-mediated initial AV-Cer transfer rate fromunilamellar vesicles. (A) Transfer of
AV-Cer from POPC donor to POPC acceptor vesicles with increasing concentration of PI
(circles) or PI4P (squares). (B) Transfer of AV-Cer from POPC donor vesicles with
increasing concentrationof PI (circles) or PI4P (squares) to POPCacceptor vesicles. 10 μg of
CERTwas used in the assay. Data in panel B are signiﬁcantly different (Pb0.05). Values are
means ± SD of at least three measurements.
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interfacial/polar region [29]. In addition, the anthrylvinyl ﬂuorophore
is nearly independent of the medium polarity [29]. The anthrylvinyl
bearing acyl chains are hydrophobic in nature, and are not looping out
to the interfacial region like, for instance, acyl chains labeled with the
more polar ﬂuorophore NBD [30–32].
It is known from previous studies that themembrane environment
largely affects different lipid transfer proteins' ability to move their
substrate from one membrane to another [33–38]. This is due to
complex processes including the substrate miscibility and interaction
with its neighboring lipids in the membrane as well as the ability of
the proteins to scan the membrane surface for their substrates.
Ceramide in natural membranes is likely to be inﬂuenced by its
surrounding lipids, much to its relatively small abundance [39,40] and
due to its small hydroxyl headgroup. The small headgroup results in a
low hydration and allows the ceramide molecules to pack tightly.
Another factor inﬂuencing the tight packing is the ability of ceramide
to function both as a hydrogen bond donor and acceptor, a capability
that ceramide shares with other sphingolipids [41,42].
A ﬂuid membrane environment appears to allow CERT to extract
ceramide from the membrane. This could be explained by the
tendency of ceramide to fuse into ceramide enriched platforms,
because of the small headgroup of ceramide and the ability to form
extensive hydrogen bonding networks with each other [20,43,44]. A
ceramide platform would be a suitable environment for CERT to bind
and extract ceramide. The lower transfer rate of AV-Cer from the POPCcontaining mixture could be a result of an interaction of AV-Cer with
POPC because of the saturated sn-1 16:0 chain. AV-Cer would not be
fully phase separated.When the saturated chain is lost as a function of
increasing the DOPC portion, AV-Cer will most likely be unable to as
effectively interact with the unsaturated bulkier 18:1 chain in position
sn-1 of DOPC and become fully separated into AV-Cer rich domains,
readily available for CERT. On the other hand, with increasing content
of gel phase lipids such as with the addition of DPPC and P-SM,
ceramide would become unavailable for CERT, presumably becoming
dispersed and in part miscible in the gel-phase [20]. It is tempting to
speculate that the ﬂuidity of the membrane could also play a role in
regulating the CERT activity in vivo.
We also observed thatwhen cholesterol between5 and 10 mol%was
added to anequimolarmixture of POPC andDPPC, the transfer of AV-Cer
appeared to be higher than the case of no cholesterol, and for mixtures
above 10 mol% cholesterol. The addition of 5–10 mol% cholesterol to a
ﬂuid and gel coexistence phase mixture such as POPC:DPPCmost likely
generates a cholesterol/DPPC phase with liquid ordered phase-like
properties [43]. In this phase the acyl chains are not in a complete all-
trans state, such as in the gel phase [44,45] but rather increases the
trans-gauge isomerization of the DPPC acyl chains. It was previously
shown extensively that ceramide is more soluble in cholesterol-rich
membranes than in cholesterol-poor membranes. At low cholesterol
amounts ceramide segregates into gel domains that disappear upon
increasing cholesterol levels [46]. It is possible that the cholesterol
generated phase dispersed in the ﬂuid and gel phase co-existence
membrane allows ceramide to localize to the phase boundarieswhere it
can be accessed by CERT. In the no cholesterol mixture, the boundaries
between the ﬂuid POPC and gel DPPC are fewer and not as suitable
environment for CERT to access ceramide, and ceramide is likely
dispersed in the DPPC phase [47]. Above 10 mol% cholesterol, liquid
ordered phase is starting to form [48–52] resulting in large liquid
ordered phase areas where ceramide would be miscible [20], and the
membrane again becomes unsuitable for CERT to access its substrate.
The accumulation of cholesterol at the phase boundaries (between
DPPC and POPC) contributes to a reduction of the interfacial line tension
between regions of different composition [53–55]. The origin of the
reduced interfacial tension is hypothesized based on simulationwork to
be a consequence of the cholesterol molecules orienting their smooth
alpha-face toward tighter packed molecules (DPPC) leaving the rough
beta-face to interact with the more ﬂuid molecules (POPC) [56,57]. If
AV-Cer also localizes to these boundary regions the amount of
cholesterol would also affect the ceramide lateral arrangement and
consequentlyCERT activity.Weacknowledge that thedifference is small
but could be explained by the effects that cholesterol has on the line
tension as well as how ceramide is solubilized in different cholesterol-
rich membranes.
The production of PI4P in Golgi is stimulated by an active ADP
ribosylation factor, ARF [58,59]. As with phosphatidylinositol phos-
phates in general, PI4P acts as a meeting point for the recruitment of
speciﬁc cytosolic proteins that contribute to the local specialization of
their surrounding membrane environment. We have shown here for
the ﬁrst time that the presence of PI4P in themembrane largely affects
CERT transfer activity speciﬁcally attracting CERT to the membrane
interface. The PH domain of CERT speciﬁcally binds to PI4P among
various recently tested phosphoinositides [3]; however, the PH
domain of a mutant CERT (G67E) did not recognize PI4P [3,25]. The
results in this study give valuable information about the effects of the
matrix surrounding the ceramide molecule. Differences in the
environment around ceramide will affect the ability of CERT to
transfer ceramide. We speculate that, when PI4P is in the acceptor
membranes, equivalent to the natural environment in the Golgi
membrane, it causes a stronger binding of CERT at the acceptor
surfaces due to the afﬁnity towards PI4P compared to the PI
containing membranes. The off rate of apo-CERT is slow from the
acceptor surface, and it is not allowed to go back to the donor
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membranes that contain PI. When CERT with a ceramide molecule
bound arrives at PI4P-containing membranes, it appears to be
arrested at the surface. We can only speculate that perhaps a PI4P-
containing membrane interface such as in Golgi could function as a
mechanism to keep CERT on the Golgi surface, and at a certain
threshold of ceramide level CERT is releasing its ceramide and is
allowed to go to the ER surface after more. On the other hand, in order
for CERT to bind to the ER membrane in vivo, VAP-A is needed that
allows CERT to bind via its FFAT motif. If the donor membrane
contains PI4P, more CERT is attracted to the membrane and
consequently faster transfer rates were observed, compared to PI
containing membranes.
In conclusion, we demonstrate that the membrane matrix
surrounding ceramide largely affects the transfer activity of CERT.
The complete transfer process is a complex event including the
protein scanning the membrane surface for its target lipid, the lipid
binding event and subsequently CERT leaving the membrane. For the
transfer to be complete, the lipid loaded protein needs to encounter a
membrane surface and unload its cargo [19,37]. These intricate steps
are regulated by a large number of factors that we are only beginning
to understand.
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